Accelus (formerly Integrity Implants) develops and manufactures medical implants used in spinal surgery.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 12/27/2022 | Series E | $165.01MM | $XXX.XX | $XXX.XX |
| 7/12/2022 | Series D | $350.02MM | $XXX.XX | $XXX.XX |
| 2/1/2020 | Series C | $136.35MM | $XXX.XX | $XXX.XX |
| 3/13/2019 | Series B | $106.65MM | $XXX.XX | $XXX.XX |
| 4/21/2016 | Series A | $46.88MM | $XXX.XX | $XXX.XX |
